Jacks Lee
Fortuna: 398 539 $ al 30/06/2026
Fortuna: 398 539 $ al 30/06/2026
Jacks Lee worked as Senior Vice President-Manufacturing & Supply at Merck & Co., Inc. from 2007 to 2023.
Served as Independent Director at G1 Therapeutics, Inc. from 2022 to 2024.
Served as Independent Director at Vaxcyte, Inc. from 2023 to 2026.
Education includes graduate degree from the University of Central Missouri and undergraduate degree from the University of Wisconsin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2026 | 6.856 ( 0 % ) | 398 539 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| VAXCYTE, INC. | Director/Miembro de la Junta | 17/06/2026 |
| G1 THERAPEUTICS, INC. | Director/Miembro de la Junta | 18/09/2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Central Missouri
University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.